Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study

被引:2
作者
Kreslova, Marcela [1 ]
Jehlicka, Petr [1 ]
Sykorova, Aneta [1 ]
Rajdl, Daniel [2 ]
Klaskova, Eva [3 ]
Prokop, Pavel [2 ]
Kapralova, Sabina [3 ]
Pavlicek, Jan [4 ]
Kaslova, Romana [1 ]
Palatova, Alzbeta [3 ]
Mohylova, Veronika [4 ]
Sykora, Josef [1 ]
机构
[1] Charles Univ Prague, Fac Med Pilsen, Fac Hosp, Dept Pediat, Alej Svobody 80, Plzen 30460, Czech Republic
[2] Charles Univ Prague, Fac Med Pilsen, Fac Hosp, Dept Clin Biochem & Hematol, Alej Svobody 80, Plzen 30460, Czech Republic
[3] Palacky Univ Olomouc, Fac Hosp, Fac Med & Dent, Dept Pediat, IP Pavlova 185-6, Olomouc 77520, Czech Republic
[4] Univ Ostrava, Fac Hosp, Dept Pediat, Fac Med, 17 Listopadu 1790, Ostrava 70852, Czech Republic
关键词
endothelial dysfunction; multisystem inflammatory syndrome; reactive hyperemia index; cystatin C; atherosclerosis; coronavirus disease 2019; biomarkers; asymmetric dimethylarginine; severe acute respiratory syndrome coronavirus 2; ASSOCIATION; COVID-19; DISEASE; HEART;
D O I
10.3390/biomedicines10112956
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Multisystem inflammatory syndrome in children (MIS-C) is a new clinical entity that has emerged in the context of the COVID-19 pandemic. Despite the less severe course of the disease, varying degrees of cardiovascular events may occur in MIS-C; however, data on vascular changes occurring in MIS-C are still lacking. Endothelial dysfunction (ED) is thought to be one of the key risk factors contributing to MIS-C. Background: We conducted a prospective observational study. We investigated possible manifestations of cardiac and endothelial involvement in MIS-C after the treatment of the acute stage and potential predictive biomarkers in patients with MIS-C. Methods: Twenty-seven consecutive pediatric subjects (>= 9 years), at least three months post-treated MIS-C of varying severity, in a stable condition, and twenty-three age- and sex-matched healthy individuals (HI), were enrolled. A combined non-invasive diagnostic approach was used to assess endothelial function as well as markers of organ damage using cardiac examination and measurement of the reactive hyperemia index (RHI), by recording the post- to pre-occlusion pulsatile volume changes and biomarkers related to ED and cardiac disease. Results: MIS-C patients exhibited a significantly lower RHI (indicative of more severe ED) than those in HI (1.32 vs. 1.80; p = 0.001). The cutoff of RHI <= 1.4 was independently associated with a higher cardiovascular risk. Age and biomarkers significantly correlated with RHI, while serum cystatin C (Cys C) levels were independently associated with a diminished RHI, suggesting Cys C as a surrogate marker of ED in MIS-C. Conclusions: Patients after MIS-C display evidence of ED, as shown by a diminished RHI and altered endothelial biomarkers. Cys C was identified as an independent indicator for the development of cardiovascular disease. The combination of these factors has the potential to better predict the cardiovascular consequences of MIS-C. Our study suggests that ED may be implicated in the pathophysiology of this disease.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Serum endocan (ESM-1) as diagnostic and prognostic biomarker in Multisystem inflammatory syndrome in children (MIS-C)
    Cannavo, Alessandro
    Gelzo, Monica
    Vinciguerra, Caterina
    Corbi, Graziamaria
    Maglione, Marco
    Tipo, Vincenzo
    Giannattasio, Antonietta
    Castaldo, Giuseppe
    CYTOKINE, 2024, 184
  • [22] Proteomic Signatures of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Narrative Review
    Dourdouna, Maria-Myrto
    Tatsi, Elizabeth-Barbara
    Syriopoulou, Vasiliki
    Michos, Athanasios
    CHILDREN-BASEL, 2024, 11 (10):
  • [23] Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age
    Campanello, Claudia
    Mercuri, Claudia
    Derchi, Maria
    Trocchio, Gianluca
    Consolaro, Alessandro
    Caorsi, Roberta
    Ravelli, Angelo
    Rimini, Alessandro
    Marasini, Maurizio
    Gattorno, Marco
    CHILDREN-BASEL, 2022, 9 (05):
  • [24] Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19
    Eveline Y. Wu
    M. Jay Campbell
    Current Cardiology Reports, 2021, 23
  • [25] Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19
    Wu, Eveline Y.
    Campbell, M. Jay
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (11)
  • [26] The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis
    Zhao, Yan
    Yin, Lijuan
    Patel, Jenil
    Tang, Lei
    Huang, Ying
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4358 - 4369
  • [27] Evaluation and follow-up in functionality in patients with Pediatric Multisystem Inflammatory Syndrome associated with COVID-19 (MIS-C)
    Alvarado-Leon, Jimena
    Cifuentes-Silva, Eduardo
    Encalada-Parra, Alejandra
    Bueno-Buker, Daniel
    ANDES PEDIATRICA, 2022, 93 (05): : 648 - 657
  • [28] Multisystem Inflammatory Syndrome in Children (MIS-C) temporally related to COVID-19: the experience at a pediatric reference hospital in Colombia
    Lozano-Espinosa, Diego Alejandro
    Camacho-Morenoa, German
    Lopez-Cubillos, Juan Francisco
    Diaz-Maldonado, Adriana Soraya
    Leon-Guerra, Oscar Javier
    Galvis-Trujillo, Diego Mauricio
    Sanguino-Lobo, Roy
    Arevalo-Leal, Oscar Guillermo
    del Castillo, Ana Maria Eraso-Diaz
    Reina-Avilaa, Maria Fernanda
    Cardenas-Hernandez, Vicky Carolina
    Ivankovich-Escoto, Gabriela
    Tremoulet, Adriana H.
    Ulloa-Gutierrez, Rolando
    REVISTA PAULISTA DE PEDIATRIA, 2023, 41 : e2021267
  • [29] Echocardiographic Findings and Correlation with Laboratory Values in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19
    Ahmet Vedat Kavurt
    Denizhan Bağrul
    Ayşe Esin Kibar Gül
    Nevin Özdemiroğlu
    İbrahim Ece
    İbrahim İlker Çetin
    Serhan Özcan
    Emel Uyar
    Serhat Emeksiz
    Elif Çelikel
    Belgin Gülhan
    Pediatric Cardiology, 2022, 43 : 413 - 425
  • [30] Systematic review on the clinical presentation and management of the COVID-19 associated multisystem inflammatory syndrome in children (MIS-C)
    Yousef, Marah Shaikh
    Idris, Nur Syazana
    Yap, Charles
    Alsubaie, Abdulaziz Abdullah
    Kakodkar, Pramath
    AIMS ALLERGY AND IMMUNOLOGY, 2021, 5 (01): : 38 - 55